$RHHBY News Article - New Data From Phase III HAVE
Post# of 16
(Total Views: 263)
Posted On: 07/11/2022 11:45:52 AM
$RHHBY News Article - New Data From Phase III HAVEN 6 Study Reinforce Favorable Safety and Efficacy Profile of Genentech's Hemlibra (emicizumab-kxwh) in People With Moderate or Mild Hemophilia A https://marketwirenews.com/news-releases/new-...82436.html
(0)
(0)Roche Hldg Ltd (RHHBY) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼